| MeSH term | MeSH ID | Detail |
|---|---|---|
| Candidemia | D058387 | 2 associated lipids |
| Aspergillosis | D001228 | 5 associated lipids |
| Blastomycosis | D001759 | 5 associated lipids |
| Xerostomia | D014987 | 6 associated lipids |
| Vaginitis | D014627 | 6 associated lipids |
| Gonorrhea | D006069 | 7 associated lipids |
| Otitis Externa | D010032 | 8 associated lipids |
| Candidiasis, Vulvovaginal | D002181 | 8 associated lipids |
| AIDS-Related Opportunistic Infections | D017088 | 9 associated lipids |
| Urethritis | D014526 | 9 associated lipids |
| Vaginosis, Bacterial | D016585 | 10 associated lipids |
| Pregnancy Complications, Infectious | D011251 | 11 associated lipids |
| Influenza, Human | D007251 | 11 associated lipids |
| Candidiasis, Oral | D002180 | 11 associated lipids |
| HIV Seropositivity | D006679 | 15 associated lipids |
| Dermatomycoses | D003881 | 17 associated lipids |
| Mycoses | D009181 | 18 associated lipids |
| Leishmaniasis | D007896 | 19 associated lipids |
| Burns | D002056 | 34 associated lipids |
| Anemia, Sickle Cell | D000755 | 34 associated lipids |
Nystatin A3
Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.
Cross Reference
Introduction
To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Nystatin A3?
Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Nystatin A3
PubChem Associated disorders and diseases
What pathways are associated with Nystatin A3
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Nystatin A3?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Nystatin A3?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Nystatin A3?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Nystatin A3?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Nystatin A3?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Nystatin A3
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Ozturk MA et al. | Oral nystatin prophylaxis to prevent invasive candidiasis in Neonatal Intensive Care Unit. | 2006 | Mycoses | pmid:17022766 |
| Messier C and Grenier D | Effect of licorice compounds licochalcone A, glabridin and glycyrrhizic acid on growth and virulence properties of Candida albicans. | 2011 | Mycoses | pmid:21615543 |
| Mousa HA and al-Bader SM | Yeast infection of burns. | 2001 | Mycoses | pmid:11486451 |
| Fernández-Campos F et al. | Evaluation of novel nystatin nanoemulsion for skin candidosis infections. | 2013 | Mycoses | pmid:22574899 |
| Blaschke-Hellmessen R and Schwarze U | Bioassay for determination of nystatin in faeces after oral application. | 1990 | Mycoses | pmid:2113608 |
| Monteiro DR et al. | Antifungal activity of silver nanoparticles in combination with nystatin and chlorhexidine digluconate against Candida albicans and Candida glabrata biofilms. | 2013 | Mycoses | pmid:23773119 |
| Auger P et al. | Treatment of cutaneous candidosis in guinea pigs: effect of zinc oxide on the antifungal efficacy of nystatin. | 1989 | Mycoses | pmid:2608092 |
| Preissner S et al. | Adjuvant antifungal therapy using tissue tolerable plasma on oral mucosa and removable dentures in oral candidiasis patients: a randomised double-blinded split-mouth pilot study. | 2016 | Mycoses | pmid:26932256 |
| Boon JM et al. | Comparison of ketoconazole suspension and nystatin in the treatment of newborns and infants with oral candidosis. | 1989 | Mycoses | pmid:2779612 |
| Blaschke-Hellmessen R et al. | [Effect of orally administered polyene antimycotics on the intestinal colonization with yeasts: possibilities and limitations]. | 1996 | Mycoses | pmid:8767267 |
| Knoke M | [Clinical pictures of orointestinal candidiasis. Fiction or reality?]. | 1996 | Mycoses | pmid:8767268 |
| Kunzelmann V et al. | [Prerequisites for effective therapy of chronic recurrent vaginal candidiasis]. | 1996 | Mycoses | pmid:8767274 |
| Sharifzadeh A et al. | Evaluation of virulence factors and antifungal susceptibility patterns of different Candida species isolated from the female camel (Camelus dromedarius) genital tract. | 2015 | Mycoses | pmid:26152466 |
| Huang CY et al. | Cutaneous hyalohyphomycosis caused by Paecilomyces lilacinus successfully treated by oral voriconazole and nystatin packing. | 2011 | Mycopathologia | pmid:21424606 |
| Charvalos E et al. | New nystatin polymeric complexes and their in vitro antifungal evaluation in a model study with Fusarium oxysporum. | 2002 | Mycopathologia | pmid:11913760 |
| Semis R et al. | Nystatin-intralipid preparation: characterization and in vitro activity against yeasts and molds. | 2010 | Mycopathologia | pmid:20069459 |
| Kantarcioglu AS et al. | Microbiota-Gut-Brain Axis: Yeast Species Isolated from Stool Samples of Children with Suspected or Diagnosed Autism Spectrum Disorders and In Vitro Susceptibility Against Nystatin and Fluconazole. | 2016 | Mycopathologia | pmid:26442855 |
| Buzzini P et al. | First large-scale isolation of Prototheca zopfii from milk produced by dairy herds in Italy. | 2004 | Mycopathologia | pmid:15630551 |
| Fan S et al. | Vaginal nystatin versus oral fluconazole for the treatment for recurrent vulvovaginal candidiasis. | 2015 | Mycopathologia | pmid:25416649 |
| Zhu Y et al. | Candida parapsilosis sensu stricto and the closely related species Candida orthopsilosis and Candida metapsilosis in vulvovaginal candidiasis. | 2015 | Mycopathologia | pmid:25322705 |